Sumedha B S, Bangalore University The novel human coronavirus, SARS-CoV-2 has created a global disease burden infecting>100 million humans in just over a year. It has become a major challenge to the health system worldwide. Detection is very crucial in this pandemic. Studies have shown that early detection is very necessary for disease control. Currently, […]
Neha khan, Jamia Millia Islamia What is the alpha variant? The B.1.1.7 variant is known as the Alpha variant which was first found in India and had taken thousands of lives. This coronavirus variant is more infectious than other variants because it foils the innate immune system for a while till it replicates and finds […]
Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University All over the world research is currently focused on the development of a drug that might help cure COVID19. At the moment we do not have any treatment for COVID19. Vaccines are the only way the chain of transmission can be broken. Throughout the pandemic, various drugs […]
Avipsha Datta, Department of Biophysics and Molecular Biology, University of Calcutta Covid-19 Vaccine- the one thing we are very much hoping for right now! Well, here is some news update that might give us a little more hope. The Drugmaker Company Moderna has announced that it is preparing to launch its potential Coronavirus vaccine mRNA-1273.Meanwhile, […]
Camelia Bhattacharyya, Amity University Kolkata The coronavirus, or the virus which has resulted in the whole world to shutdown, the ecosystem to change and us to depend completely on technology (to manage the economic conditions) and their immunity (since its more or less the survival of the fittest) first started its game in Wuhan, China. […]
Prama Ghosh, Amity University Kolkata After the recovery of President Donald Trump from Covid-19 using a similar therapy as of the antibody medicine from AstraZeneca Plc, the company has started its late-stage trials for the same against COVID-19. The medicine will undergo two trials on more than 60000 people starting soon. Astra has also planned […]
Prama Ghosh, Amity University Kolkata The alarming hypothesis that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to be around for several years calls for rapid and successful therapies. Though anti-SARS-CoV-2 spike monoclonal antibodies originated from mice have shown robust performance in various immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, there is still a […]
Anwita Sarkar, Team BioXone Based on what we know so far about the complications of COVID-19, it frequently involves complications that bear similarities to autoimmune disorders. Up to now, there are little reports on possible IgA mediated autoimmune responses. A study was conducted to determine the association of COVID-19 with vigorous total IgA responses. It […]
Srilagna Sarkar, Amity University Kolkata Coronavirus disease 2019, was first identified in Wuhan where 27 patients cases reported of pneumonia of some unknown aetiology were linked with an open seafood market. Despite several measures, the virus spread rapidly and by 11 March 2020 WHO declared it as a global pandemic. In the majority of patients […]
SAMRAT SARKAR, AMITY UNIVERSITY KOLKATA Where the entire world is trying to find a way out of this pandemic situation, Bharat Biotech with collaborated with Washington University School of Medicine in St. Louis have gone for another massive bang on the pandemic by trying a new novel chimp-adenovirus, a single-dose intranasal vaccine for Covid-19 using […]
